Xvivo System model X2 —  The 21st Century GMP Quality Platform for processing and producing clinical grade cells.

Biosafety & Containment

 

•  An unprecedented new layer of protection for people processing cells

 

•  No dependence on HVAC or brick-and-mortar

CELL THERAPY MANUFACTURING BIOHAZARDS

•  Cells from diseased patients (HIV, hepatitis, ebola, prion, TB, MRSA, etc.).

•  Virus and vectors in genetic engineered cells.

•  Off-target gene edited cells.

Quality recognizes that all personnel must be fully protected from cells harboring virus, vectors, prions, and other infectious pathogens by 100% separation and 100% containment of spills, splashes, and aerosols. Looming bio-safety concerns and associated liability must be addressed without having to depend on specialized brick-and-mortar biosafety facilities, including unclassified clinical settings. The Cytocentric X2 Platform does this now.

CYTOCENTRIC MODULAR CLOSED ASEPTIC CONTAINMENT ISOLATOR

 

Xvivo System model 2 is safer than P3 facility.

FITS ANY FACILITY

 

•  Independent of HVAC. Independent of room pressures.
•  All gases supplied from controlled remote source (tanks or generators).
•  All exhaust removed to controlled remote destination via vacuum.
•  No use of room air. No intermixing with room air. No release into room.

CONTAINMENT ELIMINATES RISK OF CROSS CONTAMINATION

 

•  Independent of HVAC. Independent of room pressures.
•  All gases supplied from controlled remote source (tanks or generators).
•  All exhaust removed to controlled remote destination via vacuum.
•  No use of room air. No intermixing with room air. No release into room.